Daniel G. Mariam

Array ( [id] => 3790650 [patent_doc_number] => 05780280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/459352 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8409 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780280.pdf [firstpage_image] =>[orig_patent_app_number] => 459352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636770 [patent_doc_number] => 06379885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/465557 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5422 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379885.pdf [firstpage_image] =>[orig_patent_app_number] => 08465557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636770 [patent_doc_number] => 06379885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/465557 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5422 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379885.pdf [firstpage_image] =>[orig_patent_app_number] => 08465557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433173 [patent_doc_number] => 06340462 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Recombinant avipox virus' [patent_app_type] => B1 [patent_app_number] => 08/455345 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20421 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340462.pdf [firstpage_image] =>[orig_patent_app_number] => 08455345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889702 [patent_doc_number] => 05750114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Recombinant herpes simplex gB-gD vaccine' [patent_app_type] => 1 [patent_app_number] => 8/452963 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 22230 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750114.pdf [firstpage_image] =>[orig_patent_app_number] => 452963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3654665 [patent_doc_number] => 05591440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Hepatitis B Virus mutants, reagents and methods for detection' [patent_app_type] => 1 [patent_app_number] => 8/447591 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19710 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591440.pdf [firstpage_image] =>[orig_patent_app_number] => 447591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855190 [patent_doc_number] => 05792462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Alphavirus RNA replicon systems' [patent_app_type] => 1 [patent_app_number] => 8/448630 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5992 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792462.pdf [firstpage_image] =>[orig_patent_app_number] => 448630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619954 [patent_doc_number] => 05593825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Hepatitis B virus mutants, reagents and methods for detection' [patent_app_type] => 1 [patent_app_number] => 8/450943 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19710 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593825.pdf [firstpage_image] =>[orig_patent_app_number] => 450943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150532 [patent_doc_number] => 06113905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases' [patent_app_type] => 1 [patent_app_number] => 8/434831 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 53 [patent_no_of_words] => 45864 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113905.pdf [firstpage_image] =>[orig_patent_app_number] => 434831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290722 [patent_doc_number] => 06180373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Microorganisms for the production of tryptophan and process for the preparation thereof' [patent_app_type] => 1 [patent_app_number] => 8/411760 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 7595 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180373.pdf [firstpage_image] =>[orig_patent_app_number] => 411760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738552 [patent_doc_number] => 05753500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Helper-free stocks of recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/417287 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12071 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753500.pdf [firstpage_image] =>[orig_patent_app_number] => 417287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034306 [patent_doc_number] => 05994503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Nucleotide and protein sequences of lats genes and methods based thereon' [patent_app_type] => 1 [patent_app_number] => 8/411111 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 15 [patent_no_of_words] => 54079 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994503.pdf [firstpage_image] =>[orig_patent_app_number] => 411111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081405 [patent_doc_number] => 06132732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Parvovirus capsids' [patent_app_type] => 1 [patent_app_number] => 8/407939 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 15 [patent_no_of_words] => 6709 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132732.pdf [firstpage_image] =>[orig_patent_app_number] => 407939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4358049 [patent_doc_number] => 06168945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Genes encoding operon and promoter for branched chain keto acid dehydrogenase of pseudomonas putida and methods' [patent_app_type] => 1 [patent_app_number] => 8/404381 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10891 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168945.pdf [firstpage_image] =>[orig_patent_app_number] => 404381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3584540 [patent_doc_number] => 05549896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines' [patent_app_type] => 1 [patent_app_number] => 8/386207 [patent_app_country] => US [patent_app_date] => 1995-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5304 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/549/05549896.pdf [firstpage_image] =>[orig_patent_app_number] => 386207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989504 [patent_doc_number] => 05891676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system' [patent_app_type] => 1 [patent_app_number] => 8/385993 [patent_app_country] => US [patent_app_date] => 1995-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891676.pdf [firstpage_image] =>[orig_patent_app_number] => 385993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870305 [patent_doc_number] => 05747039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Recombinant herpes simplex gB-gD vaccine' [patent_app_type] => 1 [patent_app_number] => 8/385731 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 22327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747039.pdf [firstpage_image] =>[orig_patent_app_number] => 385731 [rel_patent_id] =>[rel_patent_doc_number] =>)